Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Oragenics
(AMEX:OGEN)
Intraday
$1.09
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$1.09
0
[0.00%]
At close: Apr 24
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Oragenics Stock (AMEX:OGEN)
Oragenics Stock (AMEX: OGEN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, April 01, 2024
Oragenics, Inc. Files 10K And Provides Company Update
Benzinga Newsdesk
-
Apr 1, 2024, 9:09AM
Wednesday, February 28, 2024
S&P 500 Edges Lower; ADT Posts Upbeat Earnings
Avi Kapoor
-
Feb 28, 2024, 2:30PM
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Feb 28, 2024, 2:02PM
Oragenics shares are trading lower after the company announced the pricing of a $2.1 million public offering of 1.4 million shares at $1.50 per share.
Benzinga Newsdesk
-
Feb 28, 2024, 12:41PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Feb 28, 2024, 12:31PM
Nasdaq Down 50 Points; US Crude Stocks Rise By 4.2M Barrels
Avi Kapoor
-
Feb 28, 2024, 12:25PM
Dow Dips 200 Points; TJX Posts Upbeat Sales
Avi Kapoor
-
Feb 28, 2024, 10:12AM
Why Beyond Meat Shares Are Trading Higher By Around 56%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Feb 28, 2024, 8:24AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Feb 28, 2024, 8:06AM
Reported Earlier, Oragenics Prices Public Offering 1.4M Common Shares At $1.50/Share For Gross Proceeds Of $2.1M
Benzinga Newsdesk
-
Feb 28, 2024, 2:33AM
Tuesday, February 27, 2024
Oragenics Announces Proposed Public Offering
Benzinga Newsdesk
-
Feb 27, 2024, 5:53PM
Monday, February 12, 2024
Oragenics , Chief Executive Officer Kimberly Murphy Enter Mutually Agreeable Separation Agreement
Benzinga Newsdesk
-
Feb 12, 2024, 4:43PM
Wednesday, February 07, 2024
Oragenics, Inc. Announces Expiration Of Its Investment Banking Engagement Agreement
Benzinga Newsdesk
-
Feb 7, 2024, 8:19AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Feb 7, 2024, 8:06AM
Monday, February 05, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Feb 5, 2024, 4:31PM
Oragenics Prepares Phase II Clinical Trials To Treat Concussion
Benzinga Newsdesk
-
Feb 5, 2024, 8:20AM
Thursday, February 01, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Feb 1, 2024, 4:31PM
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Feb 1, 2024, 1:17PM
Why Nextracker Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Feb 1, 2024, 7:51AM
Wednesday, January 31, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Jan 31, 2024, 12:31PM
Tuesday, January 23, 2024
Oragenics Announced Termination Of At-Market Offering Program; Initiated 5-day Termination Process Of ATM Offering, With Termination To Take Effect On January 30
Charles Gross
-
Jan 23, 2024, 5:21PM
Tuesday, January 16, 2024
Oragenics Files For Offering Of Shares Of Common Stock; Size Not Disclosed
Benzinga Newsdesk
-
Jan 16, 2024, 9:12AM
Tuesday, December 12, 2023
Odyssey Health Gains Shareholder Approval for Asset Sale With Oragenics; Odyssey Received Second $500K Payment From Oragenics On Dec. 11
Benzinga Newsdesk
-
Dec 12, 2023, 8:35AM
Thursday, October 05, 2023
Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Oct 5, 2023, 1:22PM
Oragenics To Acquire Odyssey Health's Assets Related To Its Proprietary Neurological Drug Therapies And Technologies; Asset Purchase Includes Cash Payments Of $1.0M And 8M Shares Of Preferred Stock
Benzinga Newsdesk
-
Oct 5, 2023, 6:33AM
Monday, October 02, 2023
Why AERWINS Technologies Shares Are Trading Higher By Around 90%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Oct 2, 2023, 8:11AM
Friday, September 29, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Sep 29, 2023, 5:31PM
Oragenics Enters Agreement With Lantern Bioworks For Replacement-Therapy Assets; Co. Received $50K Cash Payment Alongside Opportunity To Acquire 1M Shares Of Lantern Equity, Lantern Committed To Pay 10% Royalty On Net Income Generated From Assets
Bill Haddad
-
Sep 29, 2023, 4:02PM
Wednesday, September 20, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Sep 20, 2023, 5:31PM
Monday, August 07, 2023
On August 4, Oragenics, Entered Into A $850K Securities Purchase Agreement With Two Healthcare-Focused Investors, Agreeing To Issue A Total Of 404,728 Shares Of Common Stock And 404,728 Shares Of Series E Mirroring Preferred Stock In A Private Placement
Happy Mohamed
-
Aug 7, 2023, 8:14AM
Monday, June 05, 2023
Oragenics Announces Award Of A Grant From CQDM For Development Of A Variant-Agnostic Protein Antigen For Use In Its COVID-19 Intranasal Vaccine Receives
Benzinga Newsdesk
-
Jun 5, 2023, 4:20PM
Monday, April 10, 2023
Oragenics Says On Apr. 4, Co. Concluded That Some Of Co.'s Consolidated Financial Statements Should No Longer Be Relied Upon For Interim Periods Ended March 31, 2022, June 30, 2022, Sept. 30, 2022
Michael Horton
-
Apr 10, 2023, 4:52PM
Monday, March 27, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Mar 27, 2023, 1:22PM
Friday, March 24, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Mar 24, 2023, 12:05PM
Thursday, March 23, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Mar 23, 2023, 1:11PM
Wednesday, March 15, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Mar 15, 2023, 1:25PM
Tuesday, March 14, 2023
Oragenics Reports Findings From Third Party Laboratory Testing Of Several Compounds In Oragenics' Lantibiotics Platform To Combat Multiple Pathogens Resistant To Standard-of-care Antibiotics
Benzinga Newsdesk
-
Mar 14, 2023, 8:34AM
Wednesday, March 08, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Mar 8, 2023, 10:59AM
Oragenics Appoints Janet Huffman As Chief Financial Officer Strengthening Executive Leadership Team Effective March 7
Happy Mohamed
-
Mar 8, 2023, 9:13AM
Wednesday, March 01, 2023
Oragenics Looks To Boost Potency Of Its Nasal COVID-19 Vaccine With New Licensing Pact
Vandana Singh
-
Mar 1, 2023, 11:47AM
Oragenics Enters Exclusive Global License Agreement With Inspirevax To Develop Intranasal Covid Vaccine Candidate
Bill Haddad
-
Mar 1, 2023, 7:36AM
Tuesday, February 21, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Feb 21, 2023, 12:37PM
Friday, February 03, 2023
Oragenics Regains Compliance With NYSE American's Continued Listing Standards
Benzinga Newsdesk
-
Feb 3, 2023, 7:35AM
Monday, January 23, 2023
Catalyst Pharmaceuticals, Xylem And Other Big Stocks Moving Lower On Monday
Lisa Levin
-
Jan 23, 2023, 11:36AM
Wednesday, December 28, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Dec 28, 2022, 11:23AM
Tuesday, December 27, 2022
Oragenics's Return On Capital Employed Insights
Benzinga Insights
-
Dec 27, 2022, 9:49AM
Metacrine, Equillium And 3 Stocks To Watch Heading Into Tuesday
Lisa Levin
-
Dec 27, 2022, 4:12AM
Friday, December 23, 2022
Oragenics Discloses 1-For-60 Reverse Stock Split
Benzinga Newsdesk
-
Dec 23, 2022, 4:06PM
Thursday, December 22, 2022
Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Dec 22, 2022, 1:13PM
Oragenics Highlights Encouraging Toxicology Data From Intranasal COVID Vaccine Candidate
Vandana Singh
-
Dec 22, 2022, 12:12PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch